Walleye Capital’s Urovant Sciences Ltd. UROV Stock Holding History

Walleye Capital’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-119,700	Closed	-$1.93M	–	1580
2020 Q4	$1.93M	Buy	+119,700	New	+$1.48M	0.13%	130
2018 Q3	$57K	Buy	+4,740	New	+$56.1K	0.03%	284

Walleye Capital's UROV Position: Q1 2021 in Review

Walleye Capital sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 119,700 shares — an estimated $1.93M sold.

Walleye Capital first reported a position in UROV in Q3 2018 and held it in 2 quarters. The position peaked at $1.93M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Walleye Capital reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Walleye Capital sold 119,700 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.93M.
Walleye Capital first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 2 quarters.
Walleye Capital's Urovant Sciences Ltd. position peaked at $1.93M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Walleye Capital's 13F filing for Q1 2021, filed 17 May 2021.